Loading...

Harrow Health, Inc. 11.875% Senior Notes due 2027

HROWMNASDAQ
Healthcare
Medical - Pharmaceuticals
$26.58
$0.00(0.00%)

Harrow Health, Inc. 11.875% Senior Notes due 2027 HROWM Peers

See (HROWM) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
HROWM$26.58+0.00%1.1BN/AN/A+11.16%
ONC$244.32-0.34%24.2B-67.23-$3.63N/A
INSM$98.24+0.64%18.7B-16.55-$5.94N/A
WBA$11.49+0.00%9.9B-1.58-$7.29+4.36%
HROWL$25.51-0.06%1.2BN/AN/AN/A
LFMDP$24.25+0.00%1.1B-10.75-$2.26N/A
LFMD$12.93-1.52%587M-39.14-$0.33N/A
HITI$2.34+1.74%190M-26.06-$0.09N/A
PETS$3.37+3.06%70.2M340.00$0.01N/A
YI$7.34+3.53%63.6M-3.38-$2.17N/A
Showing 1 to 10 of 21 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

HROWM vs ONC Comparison

HROWM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HROWM stands at 1.1B. In comparison, ONC has a market cap of 24.2B. Regarding current trading prices, HROWM is priced at $26.58, while ONC trades at $244.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HROWM currently has a P/E ratio of N/A, whereas ONC's P/E ratio is -67.23. In terms of profitability, HROWM's ROE is -0.28%, compared to ONC's ROE of -0.12%. Regarding short-term risk, HROWM is less volatile compared to ONC. This indicates potentially lower risk in terms of short-term price fluctuations for HROWM.

Stock Price Comparison

Loading...

Frequently Asked Questions

;